中国的ESRRG基因 综合讨论组

将WEGENE的数据导入Promethease显示PKU,但在WEGENE显示无PKU即苯丙酮尿症

rs62642941(I;I)
Phenylketonuria In dbSNP, the variant/pathogenic allele for rs62642941 is the deletion allele. However, even though they use the same identifier, the (I;I) genotype as defined by 23andMe appears to be the homozygote minor genotype causative for phenylketonuria.
是不是从WEGENE导出数据后,再导入到Promethease出了问题?
还是两家对PKU解读不一样?
 
2017-07-01 • IP属地苏州
按热门排序    按默认排序

3 个回复

josia851118 - 是个胖纸
怒赞!我也正好有这样的问题,终于答疑解惑了
同样的问题,将WEGENE的数据导入Promethease显示高帕金森风险,但是WEGENE显示帕金森风险小。
rs421016(G;G)
Gaucher disease; at least 5x higher risk of Parkinson's See discussion at rs421016.
rs421016, also known as L444P or Leu444Pro, is a SNP causing an amino acid change in the GBA gene; it is among the most common mutations associated with Gaucher disease of any type. Amino acid predictions from genome sequence may predict this as L483P or Leu483Pro; this disparity in position calling may be due to a 39 peptide signal sequence. Polyphen 2 predicts P04062 L483P to be "possibly damaging" with a score of 0.857 (sensitivity: 0.83; specificity: 0.93). ( P04062 is the uniprot ID for GBA.) The risk allele (in current dbSNP orientation) is (G), and as the inheritance is autosomal recessive, individuals must either be compound heterozygotes (for two different GBA mutations) or rs421016(G;G) homozygotes to develop Gaucher disease.
求大神解惑
费力科思 - WeGene勤杂工
苯丙酮尿症有几个位点在芯片上极不稳定,无论是affy还是illumina

要回复问题请先登录注册